Skip to main content
Fig. 2 | Trials

Fig. 2

From: Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial

Fig. 2

Schedule of enrollment, interventions, and assessments. ECOG PS, Eastern Cooperative Oncology Group performance status; EORTC QLQ-C30, version 3, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30; CT, computed tomography; MRI, magnetic resonance imaging

Back to article page

Trials

ISSN: 1745-6215